Dual Incretin + Lipolysis Activation Stack
Mechanistic Synergy for Research:
- AOD-9604 enhances fatty acid oxidation and activates key thermogenic genes like UCP-1 and PPARα in adipose tissue.
- Tirzepatide reduces appetite and improves insulin signaling, while NAD⁺ and GSH sustain the metabolic and oxidative load of lipolysis.
Combined Benefits:
- Synergistically increases metabolic rate, energy expenditure, and glucose tolerance.
- Encourages adipocyte browning and mitochondrial remodeling in fat tissue.
Use Cases:
Thermogenic peptide research, lipolytic efficiency studies, combination therapy simulations in metabolic syndrome.
